These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20335226)

  • 1. An animal model of spontaneous metabolic syndrome: Nile grass rat.
    Noda K; Melhorn MI; Zandi S; Frimmel S; Tayyari F; Hisatomi T; Almulki L; Pronczuk A; Hayes KC; Hafezi-Moghadam A
    FASEB J; 2010 Jul; 24(7):2443-53. PubMed ID: 20335226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic cataract in the Nile grass rat: A longitudinal phenotypic study of pathology formation.
    Ranaei Pirmardan E; Barakat A; Zhang Y; Naseri M; Hafezi-Moghadam A
    FASEB J; 2021 Jun; 35(6):e21593. PubMed ID: 33991133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional correlates and dynamics of diabetes in the Nile rat (Arvicanthis niloticus): a novel model for diet-induced type 2 diabetes and the metabolic syndrome.
    Chaabo F; Pronczuk A; Maslova E; Hayes K
    Nutr Metab (Lond); 2010 Apr; 7():29. PubMed ID: 20398338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of the metabolic syndrome.
    Kennedy AJ; Ellacott KL; King VL; Hasty AH
    Dis Model Mech; 2010; 3(3-4):156-66. PubMed ID: 20212084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat Models of Metabolic Syndrome.
    Kwitek AE
    Methods Mol Biol; 2019; 2018():269-285. PubMed ID: 31228162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of obesity, glucose homeostasis, dyslipidemia and fatty liver in a mouse model of diet-induced metabolic syndrome.
    Sinasac DS; Riordan JD; Spiezio SH; Yandell BS; Croniger CM; Nadeau JH
    Int J Obes (Lond); 2016 Feb; 40(2):346-55. PubMed ID: 26381349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence of metabolic syndrome and associated lifestyle factors in a worksite male population].
    Otsuka T; Kawada T; Yanai M; Kitagawa Y; Kan H
    Sangyo Eiseigaku Zasshi; 2011; 53(3):78-86. PubMed ID: 21372516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
    Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
    Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS).
    Sone H; Tanaka S; Iimuro S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Ito H; Ohashi Y; Akanuma Y; Yamada N
    J Atheroscler Thromb; 2009 Aug; 16(4):380-7. PubMed ID: 19672033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
    Bi Y; Wang JL; Li ML; Zhou J; Sun XL
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral obesity and metabolic syndrome: two faces of the same medal?
    Scaglione R; Di Chiara T; Cariello T; Licata G
    Intern Emerg Med; 2010 Apr; 5(2):111-9. PubMed ID: 19998063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the development of metabolic syndrome by the Markov model based on a longitudinal study in Dalian City.
    Tang X; Liu Q
    BMC Public Health; 2018 Jun; 18(1):707. PubMed ID: 29879952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-implant diseases and metabolic syndrome components: a systematic review.
    Papi P; Letizia C; Pilloni A; Petramala L; Saracino V; Rosella D; Pompa G
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):866-875. PubMed ID: 29509232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mediators of diabetic neuropathy: is hyperglycemia the only culprit?
    Grisold A; Callaghan BC; Feldman EL
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):103-111. PubMed ID: 28098594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan Ameliorates Nephropathy in Metabolic Syndrome by Reducing Leptin Release From Perirenal Adipose Tissue.
    Li H; Li M; Liu P; Wang Y; Zhang H; Li H; Yang S; Song Y; Yin Y; Gao L; Cheng S; Cai J; Tian G
    Hypertension; 2016 Aug; 68(2):478-90. PubMed ID: 27296996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB4 deletion predisposes to development of metabolic syndrome in mice.
    Zeng F; Wang Y; Kloepfer LA; Wang S; Harris RC
    Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E583-E593. PubMed ID: 29944391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population.
    Liu CS; Hsu HS; Li CI; Jan CI; Li TC; Lin WY; Lin T; Chen YC; Lee CC; Lin CC
    BMC Gastroenterol; 2010 May; 10():51. PubMed ID: 20507579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of a Modified High-carbohydrate High-fat Diet on Metabolic Syndrome Parameters in Male Rats.
    Wong SK; Chin KY; Suhaimi FH; Ahmad F; Ima-Nirwana S
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):205-212. PubMed ID: 29117620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM).
    Subramaniam A; Landstrom M; Luu A; Hayes KC
    Nutrients; 2018 Feb; 10(2):. PubMed ID: 29463026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes.
    Hye Khan MA; Kolb L; Skibba M; Hartmann M; Blöcher R; Proschak E; Imig JD
    Diabetologia; 2018 Oct; 61(10):2235-2246. PubMed ID: 30032428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.